Artiva Biotherapeutics, Inc. Common Stock (ARTV) Financials

$5.87

north_east
$0.77 (15.1%)
Day's range
$5.05
Day's range
$5.89
$40M$40M$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80MEarning202020202021202120222022202320230%0%-1000%-1000%-2000%-2000%-3000%-3000%-4000%-4000%-5000%-5000%-6000%-6000%Profit Margin
Profit Margin
Revenue
Earnings

ARTV Income statement / Annual

Last year (2023), Artiva Biotherapeutics, Inc.'s total revenue was $33.49 M, an increase of 579.21% from the previous year. In 2023, Artiva Biotherapeutics, Inc.'s net income was -$27.70 M. See Artiva Biotherapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Operating Revenue $33.49 M $4.93 M $2.00 M $0.00
Cost of Revenue $0.00 $0.00 $0.00 $0.00
Gross Profit $33.49 M $4.93 M $2.00 M $0.00
Gross Profit Ratio 1 1 1 0
Research and Development Expenses $50.25 M $43.98 M $42.41 M $13.85 M
General & Administrative Expenses $13.91 M $20.78 M $12.86 M $4.43 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $13.91 M $20.78 M $12.86 M $4.43 M
Other Expenses $0.00 $200,000.00 -$18.55 M $477,000.00
Operating Expenses $64.16 M $64.76 M $55.27 M $18.27 M
Cost And Expenses $64.16 M $64.76 M $55.27 M $18.27 M
Interest Income $2.54 M $1.29 M $0.00 $2,000.00
Interest Expense $0.00 $0.00 $0.00 $199,000.00
Depreciation & Amortization $2.27 M $1.16 M $248,000.00 $73,000.00
EBITDA -$28.41 M -$58.67 M -$71.58 M -$17.72 M
EBITDA Ratio -0.85 -11.9 -35.75 0
Operating Income Ratio -0.92 -12.13 -26.61 0
Total Other Income/Expenses Net $3.05 M $1.49 M -$18.55 M $280,000.00
Income Before Tax -$27.62 M -$58.34 M -$71.83 M -$17.99 M
Income Before Tax Ratio -0.82 -11.83 -35.88 0
Income Tax Expense $72,000.00 $53,000.00 -$18.55 M $676,000.00
Net Income -$27.70 M -$58.39 M -$71.83 M -$17.99 M
Net Income Ratio -0.83 -11.84 -35.88 0
EPS -2.96 -3.32 -4.08 -1.02
EPS Diluted -2.96 -3.32 -4.08 -1.02
Weighted Average Shares Out $9.35 M $17.58 M $17.58 M $17.58 M
Weighted Average Shares Out Diluted $9.35 M $17.58 M $17.58 M $17.58 M
Link